AGENUS INC Increase (Decrease) in Deferred Revenue
AGENUS INC (AGEN) reported Increase (Decrease) in Deferred Revenue of -$472.95 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-10
- AGENUS INC increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$472.95K.
- AGENUS INC increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$715.16K.
- AGENUS INC increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$888.97K.
- AGENUS INC increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$465.25K.
- AGENUS INC increase (decrease) in deferred revenue for fiscal 2017 was -$2.72M.
- AGENUS INC increase (decrease) in deferred revenue for fiscal 2016 was -$3.94M, a 124.69% decline from fiscal 2015.
- AGENUS INC increase (decrease) in deferred revenue for fiscal 2015 was $15.96M.
- AGENUS INC increase (decrease) in deferred revenue for fiscal 2014 was -$3.61M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$472.95K 10-Q · filed 2018-05-10 | -$1.19M derived: sum of 2 quarters · filed 2018-05-10 | -$2.08M derived: sum of 3 quarters · filed 2018-05-10 | -$2.54M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | -$715.16K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$1.60M derived: sum of 2 quarters · filed 2018-03-16 | -$2.07M derived: sum of 3 quarters · filed 2018-03-16 | -$2.72M 10-K · filed 2018-03-16 |
| 2017-09-30 | -$888.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.35M derived: sum of 2 quarters · filed 2017-11-07 | -$2.01M 10-Q · filed 2017-11-07 | -$2.66M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | -$465.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$1.12M 10-Q · filed 2017-08-07 | -$1.77M derived: sum of 3 quarters · filed 2018-05-10 | -$2.43M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | -$652.63K 10-Q · filed 2018-05-10 | -$1.31M derived: sum of 2 quarters · filed 2018-05-10 | -$1.96M derived: sum of 3 quarters · filed 2018-05-10 | -$3.05M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | -$652.63K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$1.31M derived: sum of 2 quarters · filed 2018-03-16 | -$2.40M derived: sum of 3 quarters · filed 2018-03-16 | -$3.94M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$657.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.75M derived: sum of 2 quarters · filed 2017-11-07 | -$3.29M 10-Q · filed 2017-11-07 | -$5.79M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$2.63M 10-Q · filed 2017-08-07 | -$5.14M derived: sum of 3 quarters · filed 2018-03-16 | -$7.63M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$1.54M 10-Q · filed 2017-05-04 | -$4.05M derived: sum of 2 quarters · filed 2018-03-16 | -$6.53M derived: sum of 3 quarters · filed 2018-03-16 | -$9.22M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$5.00M derived: sum of 2 quarters · filed 2018-03-16 | -$7.68M derived: sum of 3 quarters · filed 2018-03-16 | $15.96M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$5.17M derived: sum of 2 quarters · filed 2016-11-09 | $18.47M 10-Q · filed 2016-11-09 | $17.55M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $20.95M 10-Q · filed 2016-08-04 | $20.04M derived: sum of 3 quarters · filed 2017-03-16 | $18.57M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $23.64M 10-Q · filed 2016-05-09 | $22.72M derived: sum of 2 quarters · filed 2017-03-16 | $21.25M derived: sum of 3 quarters · filed 2017-03-16 | $20.71M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | -$915.07K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$2.38M derived: sum of 2 quarters · filed 2017-03-16 | -$2.92M derived: sum of 3 quarters · filed 2017-03-16 | -$3.61M 10-K · filed 2017-03-16 |
| 2014-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$2.01M derived: sum of 2 quarters · filed 2015-11-04 | -$2.70M 10-Q · filed 2015-11-04 | -$2.92M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | -$540.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | -$1.23M 10-Q · filed 2015-08-03 | -$1.46M derived: sum of 3 quarters · filed 2016-03-15 | -$1.83M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | -$688.90K 10-Q · filed 2015-05-01 | -$916.57K derived: sum of 2 quarters · filed 2016-03-15 | -$1.29M derived: sum of 3 quarters · filed 2016-03-15 | -$1.78M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | -$227.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$605.34K derived: sum of 2 quarters · filed 2016-03-15 | -$1.09M derived: sum of 3 quarters · filed 2016-03-15 | -$1.47M 10-K · filed 2016-03-15 |
| 2013-09-30 | -$377.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$864.53K derived: sum of 2 quarters · filed 2014-10-31 | -$1.25M 10-Q · filed 2014-10-31 | $121.53K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$486.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$868.83K 10-Q · filed 2014-08-01 | $499.20K derived: sum of 3 quarters · filed 2015-03-16 | $117.23K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | -$381.97K 10-Q · filed 2014-05-09 | $986.06K derived: sum of 2 quarters · filed 2015-03-16 | $604.09K derived: sum of 3 quarters · filed 2015-03-16 | $215.74K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $986.06K derived: sum of 2 quarters · filed 2015-03-16 | $597.71K derived: sum of 3 quarters · filed 2015-03-16 | $2.71M 10-K · filed 2015-03-16 |
| 2012-09-30 | -$381.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$770.32K derived: sum of 2 quarters · filed 2013-11-08 | $1.34M 10-Q · filed 2013-11-08 | $949.49K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$388.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.72M 10-Q · filed 2013-08-09 | $1.33M derived: sum of 3 quarters · filed 2014-03-07 | $960.25K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $2.11M 10-Q · filed 2013-05-10 | $1.72M derived: sum of 2 quarters · filed 2014-03-07 | $1.35M derived: sum of 3 quarters · filed 2014-03-07 | $963.50K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | -$390.10K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$761.30K derived: sum of 2 quarters · filed 2014-03-07 | -$1.15M derived: sum of 3 quarters · filed 2014-03-07 | -$1.53M 10-K · filed 2014-03-07 |
| 2011-09-30 | -$371.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$756.30K derived: sum of 2 quarters · filed 2012-11-07 | -$1.14M 10-Q · filed 2012-11-07 | $223.50K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$385.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$770.19K 10-Q · filed 2012-08-08 | $594.71K derived: sum of 3 quarters · filed 2013-03-18 | $209.61K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$385.10K 10-Q · filed 2012-05-09 | $979.80K derived: sum of 2 quarters · filed 2013-03-18 | $594.71K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $979.80K derived: sum of 2 quarters · filed 2013-03-18 | $674.10K 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$385.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$690.80K 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | -$305.70K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$440.40K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |